http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105147667-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741 |
| filingDate | 2015-07-27^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-12^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-12^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105147667-B |
| titleOfInvention | The application of Skp1 cancer proteins and its targeted drug in oncotherapy |
| abstract | The application of Skp1 cancer proteins and its targeted drug in oncotherapy.The method for being used to prepare tumor-targeting drug includes：Screening can effectively reduce the compound of Skp1 oncoprotein height expression；And prepare corresponding tumor-targeting drug using the compound.Tumor-targeting drug according to the present invention can inhibit tumor cell proliferation and cell cycle to reach antitumous effect by combining Skp1 to inhibit SCF E3 connection enzymatic activitys. |
| priorityDate | 2015-07-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 86 of 86.